COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,693 Articles (22,913 medRxiv, 8,780 bioRxiv)

Most recent first Previous |  Page 177: Articles 1761-1770  | Next

Systemic exposure to COVID-19 virus-like particles modulates firing patterns of cortical neurons in the living mouse brain
Das, A., Icardi, J., Borovicka, J., Holden, S., Harrison, H. F., Hirsch, A. J., Raber, J., Dana, H.
10.1101/2024.11.26.625543 — Posted: 2024-11-27
The identification of a SARs-CoV2 S1 protein derived peptide with super-antigen-like stimulatory properties on T-cells
Tu, T. H., Bennani, F. E., Masroori, N., Liu, C., Nemati, A., Rozza, N., Grunbaum, A. M., Kremer, R., Milhalcioiu, C., Roy, D.-C., Rudd, C.
10.1101/2024.11.26.624714 — Posted: 2024-11-27
Prediction of Pediatric No-Show Rates Before and During the COVID-19 Pandemic Utilizing Machine Learning.
Hathaway, Q., Yanamala, N., Narumanchi, T., Narumanchi, J.
10.1101/2024.11.23.24317836 — Posted: 2024-11-26
Virtual rehabilitation for individuals with Long COVID: a randomized controlled trial.
Janaudis-Ferreira, T., Beauchamp, M. K., Rizk, A., Tansey, C. M., Sedeno, M., Barreto, L., Bourbeau, J., Ross, B. A., Benedetti, A., Li, P. Z., Agarwal, K., Zucco, R., Lopez, J., Crowley, E., Cloutier, J.
10.1101/2024.11.24.24317856 — Posted: 2024-11-26
A Cross-Sectional Survey of Knowledge, Attitudes and Practices (KAP) towards COVID-19 in working professionals of Islamabad during lockdown
Nisar, N., Badar, N., Safdar, I., Haider, M., Yaqoob, A.
10.1101/2024.11.24.24317870 — Posted: 2024-11-26
Association between COVID-19 Disease Severity and T Cell Receptor Repertoire
Chen, X., Su, Y., Dai, C., Goldman, J. D., Heath, J. R., Liu, S., Sun, W.
10.1101/2024.11.26.625333 — Posted: 2024-11-26
Diverse patterns of intra-host genetic diversity in chronically infected SARS-CoV-2 patients
Rutsinsky, N., Ben Zvi, A., Fabian, I., Segev, S. T., Jacobi, B., Harari, S., Meijers, S., Paran, Y., Stern, A.
10.1101/2024.11.23.624482 — Posted: 2024-11-25
Naturally occurring N-terminal mutations in SARS-CoV-2 nsp1 impact innate immune modulation but do not affect virus virulence
Rani, R., Nooruzzaman, M., Caserta, L. C., Diel, D.
10.1101/2024.11.23.624996 — Posted: 2024-11-25
Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine
Hernandez, G., Osinski, A., Majumdar, A., Eitson, J. L., Antczak, M., Pawlowski, K., Niederstrasser, H., Servage, K. A., Posner, B., Schoggins, J. W., Ready, J. A., Tagliabracci, V. S.
10.1101/2024.11.22.624893 — Posted: 2024-11-25
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
Wang, K., Nie, Y., Maguire, C., Syphurs, C., Sheen, H., Karoly, M., Lapp, L., Gygi, J. P., Jayavelu, N. D., Patel, R. K., Hoch, A., IMPACC Network, , Corry, D., Kheradmand, F., McComsey, G. A., Fernandez-Sesma, A., Simon, V., Metcalf, J. P., Agudelo Higuita, N. I., Messer, W. B., David, M. M., Nadeau, K. C., Kraft, M., Bime, C., Schaenman, J., Erle, D., Calfee, C. S., Atkinson, M. A., Brackenridge, S. C., Hafler, D. A., Shaw, A. C., Rahman, A., Hough, C. L., Geng, L. N., Ozonoff, A., Haddad, E. K., Reed, E. F., Bakel, H. v., Kim-Schulze, S. H., Krammer, F., Wilson, M., Eckalbar, W., Bosinger, S., Langelier, C. R., Selaky, R., Montgomery, R. R., Maecker, H., Krumholz, H., Melamed, E., Steen, H., Pulendran, B., Augustine, A. D., Cairns, C. B., Rouphael, N., Becker, P. M., Fourati, S., Shannon, C. P., Smolen, K. K., Peters, B., Kleinstein, S. H., Levy, O., Altman, M. C., Iwasaki, A., Diray-Arce, J., Ehrlich, L. I. R., Guan, L.
10.1101/2024.11.22.624784 — Posted: 2024-11-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).